
This episode discusses the optimization of lipid nanoparticles for enhanced CRISPR/Cas9 delivery in lung tumor models.
This webinar recording features the work of Dr. Carneiro's team on optimizing lipid nanoparticles (LNPs) to enhance CRISPR/Cas9 delivery and effectiveness in targeting KRAS mutations in lung tumors.
Explore listener stats, chart rankings, contacts and more on the The antibody-based pharmaceuticals resource library’s Podcast podcast page.